EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy

Beinan Han, Xiaorong Lin, Hai Hu

Translational Breast Cancer Research · 2024-10 · 5 · 33-33

DOI: 10.21037/tbcr-24-29 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Breast Cancer Research, 2024-10. Verfasst von Beinan Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Die Arbeit wurde bisher 47-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PI3K inhibitorPhosphatidylinositol-3-kinase (PI3K)cancermetabolismtarget therapy

Autor:innen und Institutionen

  • Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Diagnosis and Treatment Center of Breast Diseases, Shantou Central Hospital, Shantou, China.
  • The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.

Zitieren

APA

Han, B., Lin, X., & Hu, H. (2024). Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy. Translational Breast Cancer Research, 5, 33-33. https://doi.org/10.21037/tbcr-24-29

Vancouver

Han B, Lin X, Hu H. Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy. Translational Breast Cancer Research. 2024;5:33-33. doi:10.21037/tbcr-24-29

BibTeX
@article{Han2024,
  author = {Han, Beinan and Lin, Xiaorong and Hu, Hai},
  title = {Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy},
  journal = {Translational Breast Cancer Research},
  year = {2024},
  volume = {5},
  pages = {33--33},
  doi = {10.21037/tbcr-24-29}
}
Kostenlos starten →